Robert MacLeod
Vermogen: - $ op 31-08-2026
Vermogen: - $ op 31-08-2026
Robert A. MacLeod started working at ADARx Pharmaceuticals, Inc. in 2023.
The current position held is Chief Scientific Officer at ADARx Pharmaceuticals, Inc. since 2023.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 25-09-2026 | 0 ( -.--% ) | - $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ADARX PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
Flamingo Therapeutics BV
Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Provides RNA therapeutic drug development services | Hoofd Techniek/Wetenschap/O&O | 01-12-2022 |
| IONIS PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-09-2021 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Concordia University
Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pipeline that develops RNA medicines for diseases | Commercial Services |
Flamingo Therapeutics BV
Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Provides RNA therapeutic drug development services | Commercial Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau